Table 4.
Effect of CXCL16 or CXCR6 expression in the tumor on patient overall survival according to “The Human Protein Atlas” (https://www.proteinatlas.org, accessed on 15 January 2021) [182,183].
| Type of Cancer | Overall Survival for Increased CXCL16 Expression in the Tumor | Overall Survival for Increased Expression of CXCR6 in the Tumor |
|---|---|---|
| Glioma | ↓p = 0.094 | ↓p = 0.078 |
| Thyroid cancer | ↑ | ↑ |
| Lung cancer | -- | ↑ |
| Colorectal cancer | -- | ↑ |
| Head and neck cancer | -- | ↑ |
| Stomach cancer | ↓ | ↑ |
| Liver cancer | ↓ | ↑ |
| Pancreatic cancer | ↑ | -- |
| Renal cancer | ↑ | ↓ |
| Urothelial cancer | -- | ↑ |
| Prostate cancer | -- | -- |
| Testis cancer | ↓ | ↓ |
| Breast cancer | ↑ | ↑ |
| Cervical cancer | ↑p = 0.052 | ↑ |
| Endometrial cancer | ↓ | ↑ |
| Ovarian cancer | -- | ↑ |
| Melanoma | -- | ↑ |
↑ blue background-better overall survival; ↓ red background–poorer overall survival; --–no correlation.